ReleaseWire Connect

Agilent Technologies, Inc. (Agilent) provides instruments, reagents, software, services and consumables for life sciences, diagnostics and applied chemical markets. The company offers its products to pharmaceutical, biotechnology, CRO and CMO, chemical and energy, environmental and forensics, and food industries. The company conducts research and development activities through its research arm Agilent Technologies Research Laboratories. The company markets its products through direct sales. It works with customers in more than 100 countries and it has subsidiaries in Denmark, Luxembourg, Netherlands, Singapore and Switzerland. Agilent is headquartered in Santa Clara, California, the US.Agilent seeks to expand its position in the market through new product launches. Recently the company launched aloPlex target enrichment system, ClearSeq Comprehensive Cancer research panel, SureVector modular vector kit and Portable FTIR Package, among others.

Illumina, Inc. (Illumina) is a molecular diagnostics company. It develops, manufactures and markets life science tools and integrated systems for genetic variation and function analysis. The company offers solutions for copy number variation, single nucleotide polymorphism genotyping, gene expression profiling of DNA and RNA, and deoxyribonucleic acid methylation studies. Illumina offers its services to pharmaceutical companies, genomic research centers, academic institutions, biotechnology companies and clinical research organizations. The products offered by Illumina for genomic analysis include HiSeq 2500, NextSeq 500, MiSeq, HiScanSQ systems. The core technologies of the company include Sequencing by Synthesis (SBS), BeadArray and Real-Time PCR technology. The company's products are distributed to various countries through its distributors in Europe, India, Israel, Korea, Malaysia, Greece, Turkey, Taiwan, Thailand, Vietnam, South Africa, Saudi Arabia, Russia, Ukraine, Belarus and other countries. Illumina is headquartered in San Diego, California, the US.

Sanofi is a diversified global healthcare company. It undertakes the discovery, development and marketing of therapeutic solutions. The company offers a broad range of prescription medicines, and consumer healthcare and generic products worldwide..The company offers Pharmaceutical products in the areas of cancer, cardiovascular diseases, thrombosis, diabetes, central nervous system (CNS) disorders, general diseases such as benign prostatic hyperplasia, osteoporosis and rheumatoid arthritis. Sanofi offers vaccines such as pediatric combinations and poliomyelitis vaccines, influenza, adult and adolescent booster, meningitis, travel and endemic, and measles, mumps and rubella (MMR). It also provides an array of medicines and vaccines for a wide range of animal species. Sanofi is headquartered in Paris, France.

Meridian Bioscience, Inc. (Meridian) is a fully integrated life science company that manufactures diagnostic test kits for gastrointestinal, viral, respiratory, and parasitic infectious disease indications. It also manufactures bulk antigens, antibodies, purified reagents, nucleotides and related products for use in research and diagnostic manufacturing. Meridian develops proteins and other biological materials for use in biotechnology research for new drugs and vaccines. It has over 140 diagnostic tests and transport media, spanning from prenatal care, respiratory infections, and organ transplant infections among other infectious disease areas. Meridian offers its products to hospitals, clinics, veterinary testing centers, reference laboratories, research centers, physician offices, and diagnostics manufacturers in over 60 countries the world over. Meridian is headquartered in Ohio, the US.Meridian seeks to establish development and marketing partnerships, research collaborations, technology in-licensing with other companies which would enhance the company's capabilities, clinical program and product pipeline. The company focuses on its product portfolio expansion by building strong operating base besides gaining expertise through strategic agreements and collaborations.

BioMark Technologies Inc. (BioMark Technologies) is a biotechnology service providing company which develops and provides a range of portable screening tools for the treatment of cancers. The company manufactures and distributes diagnostic systems for the detection and diagnosis of cancer. It offers its technology for diagnosis, response to treatment, prognosis and drug therapy. BioMark Technologies partners with various other healthcare providers, universities and research and development organizations. The company has its presence in China and Canada. BioMark Technologies is headquartered in Richmond, British Columbia, Canada.

Merit Medical Systems, Inc. (Merit) offers a wide variety of single-use medical devices for use in interventional and diagnostic procedures. The company's products include inflation devices and accessories, diagnostic and therapeutic catheters, diagnostic and hydrophilic products, thrombolytic catheters and fluid dispensing systems, and embolotherapeutic products. These products find applications in various diagnostic and interventional cardiology fields such as radiology, cardiology, and endoscopy. Merits products are also used in other clinical areas such as thoracic surgery, interventional nephrology, vascular surgery, oncology, and pain management. The company markets its products through direct sales force in the US and Europe, and China and through independent dealer organizations and network of OEM partners in the Europe, Africa, the Middle East, Asia, South and Central America, Oceania, and Canada. Merit is headquartered in South Jordan, Utah, the US.The company focuses on expanding its product portfolio through constant innovations. To this end, Merit obtained regulatory approvals for its ReSolve biliary locking drainage catheter, ONE Snare endovascular microsnare system, and AEROmini tracheobronchial stent system.

Varian Medical Systems, Inc. (Varian) is a provider of medical devices and software for the treatment of cancer. It designs, manufactures and sells equipment and software for the diagnosis and treatment of cancer and other medical conditions through radiotherapy, radiosurgery, proton therapy and brachytherapy. The company offers X-ray tubes and digital image detectors that are used in medical, dental, veterinary, scientific and industrial sectors. It designs, manufactures, sells and services linear accelerators, image processing software and image detection products for security and inspection purposes and proton therapy products and systems for cancer treatment. The company, together with its subsidiaries and manufacturing facilities, operates in North America, Europe, Asia-Pacific, the Middle East and Africa. Varian is headquartered in Palo Alto, California, the US.Varian secured the US FDA approval for several products including Truebeam Stx-Edge radiotherapy delivery system Varian Head Frame Varian Verification system Universal Segmented Cylinder Applicator and Smart Segmentation Knowledge Based Contouring system, among others. These approvals enable the company to expand its operations in the US.

Masimo Corporation (Masimo) is a global medical technology company. It manufactures and distributes non-invasive patient monitoring technologies such as medical devices and a broad range of sensors to improve patient care. Signal Extraction Technology (SET) is the company's lead technology that helps detect life threatening events. Other technologies of Masimo include Pulse CO-Oximetry which allows noninvasive and continuous monitoring of blood constituents, brain and breathand Patient SafetyNet, a remote monitoring and wireless clinician notification system. The company's key products include pulse oximeters, patient monitors, patient cables, central monitoring systems, specialty sensors, circuit boards, remote-alarm, and monitoring solutions. It markets these products directly and through distributors and original equipment manufacturers (OEMs) to hospitals, emergency medical services (EMS), physician offices, veterinarians, long term care facilities, and consumers market. The company operates in various markets across North and South America, Europe, the Middle East, Africa, Asia, and Australia. Masimo is headquartered in Irvine, California, the US.

This report provides readers with a comprehensive analysis of the Government Biometric Systems market through 2013-2023, including highlights of the demand drivers and growth stimulators for Government Biometric Systems. It also provides an insight on the spending pattern and modernization pattern in different regions around the world.

This report provides information on major programs planned in the global Government Biometric Systems market. It provides details on top programs in each segment expected to be executed during the forecast period.